Nooshin Dalili
Tehran, Iran, Islamic Republic of
University in Tehran
Tehran Province, Tehran, Velenjak، 7th Floor, Bldg No.2 SBUMS, Arabi Ave
About Nooshin Dalili
Shahid Beheshti University of Medical Sciences is one of the three medical universities in Tehran, the capital of Iran. It began in 1961 with the establishment of the Schools of Medicine and Dentistry.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Nooshin Dalili
During the past decade, Nooshin Dalili conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
2000-10-01
Unknown status
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
2002-06-01
Unknown status
Determination of Carboplatin's Optimal Plasmatic Exposure
2005-05-01
2009-02-01
Completed
400
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer
2005-09-01
Completed
835
Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)
2009-01-01
2018-07-01
Terminated
335
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
2010-04-01
2014-12-01
Completed
183
Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
2011-10-01
2014-02-01
Completed
2,114
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Nooshin Dalili
According to Clinical.Site data, the most researched conditions in "Nooshin Dalili" are
"COVID-19" (3 trials), "Ckd-Mbd" (1 trials), "Contrast-induced Nephropathy" (1 trials), "Coronary Angiography" (1 trials) and "Cytomegalovirus Infections" (1 trials). Many other conditions were trialed in "Nooshin Dalili" in a lesser frequency.
Clinical Trials Intervention Types at Nooshin Dalili
Most popular intervention types in "Nooshin Dalili" are "Diagnostic Test" (3 trials), "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "CPET" (1 trials), "Colchicine Tablets" (1 trials), "Coronary Angiography" (1 trials), "Cycle threshold" (1 trials) and "Everolimus Pill" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nooshin Dalili
The vast majority of trials in "Nooshin Dalili" are
7 trials for "All" genders.
Clinical Trials Status at Nooshin Dalili
Currently, there are NaN active trials in "Nooshin Dalili".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Nooshin Dalili,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nooshin Dalili, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".